Metabolism of Diosbulbin B In Vitro and In Vivo in Rats: Formation of Reactive Metabolites and Human Enzymes Involved

Diosbulbin B (DB), a major constituent of the furano-norditerpenes in Dioscorea bulbifera Linn, exhibits potential antineoplasmic activity and hepatotoxicity. The metabolism and reactive metabolites of DB in vitro (with human and animal liver microsomes) and in vivo in rats were investigated. The human enzymes involved in DB metabolism were identified. DB was first catalyzed into reactive metabolites of 2-butene-1,4-dial derivatives dependent on NADPH and then trapped by Tris base or oxidized to hemiacetal lactones (M12 and M13) in microsomal incubations. Tris base was used as buffer constituent and as a trapping agent for aldehyde. Methoxylamine and glutathione (GSH) were also used as trapping agents. DB metabolism in vivo in rats after oral administration was consistent with that in vitro. The structures of M12 and M13, as well as mono-GSH conjugates of DB (M31), were confirmed by nuclear magnetic resonance spectroscopy of the chemically synthesized products. The bioactivation enzymes of DB were identified as CYP3A4/5, 2C9, and 2C19. CYP3A4 was found to be the primary enzyme using human recombinant cytochrome P450 enzymes, specific inhibitory studies, and a relative activity factor approach for pooled human liver microsomes. Michaelis-Menten constants Km and Vmax were determined by the formation of M31. The reactive metabolites may be related to the hepatotoxicity of DB. The gender difference in CYP3A expression in mice and rats contributed to the gender-related liver injury and pharmacokinetics in mice and rats, respectively.

[1]  Kaixian Chen,et al.  Gender-related pharmacokinetics and absolute bioavailability of diosbulbin B in rats determined by ultra-performance liquid chromatography-tandem mass spectrometry. , 2013, Journal of ethnopharmacology.

[2]  Zheng Wang,et al.  Antitumor activity of Dioscorea bulbifera L. rhizome in vivo. , 2012, Fitoterapia.

[3]  K. Chibale,et al.  Identification and characterization of reactive metabolites in natural products-driven drug discovery. , 2012, Journal of natural products.

[4]  Zhengtao Wang,et al.  Gender-related difference in liver injury induced by Dioscorea bulbifera L. rhizome in mice , 2011, Human & experimental toxicology.

[5]  Zheng-Tao Wang,et al.  Norclerodane diterpenoids from rhizomes of Dioscorea bulbifera. , 2010, Phytochemistry.

[6]  L. Peterson,et al.  Identification of furan metabolites derived from cysteine-cis-2-butene-1,4-dial-lysine cross-links. , 2010, Chemical research in toxicology.

[7]  Jikai Liu,et al.  Two new furanoid norditerpenes from Dioscorea bulbifera. , 2009, Chemical & pharmaceutical bulletin.

[8]  Martin B Phillips,et al.  Degraded protein adducts of cis-2-butene-1,4-dial are urinary and hepatocyte metabolites of furan. , 2009, Chemical research in toxicology.

[9]  J. H. Beijnen,et al.  Nuclear receptor mediated induction of cytochrome P450 3A4 by anticancer drugs: a key role for the pregnane X receptor , 2009, Cancer Chemotherapy and Pharmacology.

[10]  L. Marnett,et al.  Characterization of the amino acid adducts of the enedial derivative of teucrin A. , 2006, Chemical research in toxicology.

[11]  L. Peterson,et al.  Identification of a cis-2-butene-1,4-dial-derived glutathione conjugate in the urine of furan-treated rats. , 2006, Chemical research in toxicology.

[12]  Roger A. Jones,et al.  Detection of DNA adducts derived from the reactive metabolite of furan, cis-2-butene-1,4-dial. , 2006, Chemical research in toxicology.

[13]  J. Goldstein,et al.  Induction of Human CYP2C9 by Rifampicin, Hyperforin, and Phenobarbital Is Mediated by the Pregnane X Receptor , 2004, Journal of Pharmacology and Experimental Therapeutics.

[14]  Laura P James,et al.  Acetaminophen‐Induced Hepatotoxicity: Role of Metabolic Activation, Reactive Oxygen/Nitrogen Species, and Mitochondrial Permeability Transition , 2004, Drug metabolism reviews.

[15]  R. Obach,et al.  Verification of the selectivity of (+)N-3-benzylnirvanol as a CYP2C19 inhibitor. , 2003, Drug metabolism and disposition: the biological fate of chemicals.

[16]  G. Murray,et al.  Tumour cytochrome P450 and drug activation. , 2002, Current pharmaceutical design.

[17]  Karthik Venkatakrishnan,et al.  Human Drug Metabolism and the Cytochromes P450: Application and Relevance of In Vitro Models , 2001, Journal of clinical pharmacology.

[18]  T. Baillie,et al.  Studies on the metabolism of troglitazone to reactive intermediates in vitro and in vivo. Evidence for novel biotransformation pathways involving quinone methide formation and thiazolidinedione ring scission. , 2001, Chemical research in toxicology.

[19]  C L Crespi,et al.  The use of heterologously expressed drug metabolizing enzymes--state of the art and prospects for the future. , 1999, Pharmacology & therapeutics.

[20]  R. Murray,et al.  Synthesis of Epoxides Using Dimethyldioxirane: trans‐Stilbene Oxide , 2003 .

[21]  T. Komori.  Glycosides from Dioscorea bulbifera. , 1997, Toxicon : official journal of the International Society on Toxinology.

[22]  L. J. Chen,et al.  Characterization of amino acid and glutathione adducts of cis-2-butene-1,4-dial, a reactive metabolite of furan. , 1997, Chemical research in toxicology.

[23]  N. Schnetz-Boutaud,et al.  Temperature-dependent formation of a conjugate between tris(hydroxymethyl)aminomethane buffer and the malondialdehyde-DNA adduct pyrimidopurinone. , 1997, Chemical research in toxicology.

[24]  B. Arison,et al.  Microsomal metabolism of the 5-lipoxygenase inhibitor L-739,010: evidence for furan bioactivation. , 1996, Chemical research in toxicology.

[25]  L A Peterson,et al.  Identification of cis-2-butene-1,4-dial as a microsomal metabolite of furan. , 1995, Chemical research in toxicology.

[26]  T. Kimura,et al.  Diosbulbin-B from the Leaves and Stems of Dioscorea bulbifera: 1H-1H and 13C-1H COSY NMR Studies. , 1993, Planta medica.

[27]  R Kato,et al.  Sex-specific cytochrome P450 as a cause of sex- and species-related differences in drug toxicity. , 1992, Toxicology letters.

[28]  R. Irwin,et al.  Disposition of [14C]furan in the male F344 rat. , 1991, Journal of toxicology and environmental health.

[29]  Tetsuya Komori,et al.  Furanoid‐norditerpene aus Pflanzen der Familie Dioscoreaceae, V. Struktur der Diosbulbine‐D, ‐E, ‐F, ‐G und ‐H , 1978 .

[30]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[31]  D. J. Cannon,et al.  A stabilised tris(hydroxymethyl)aminomethane adduct in reduced collagen. , 1976, Connective tissue research.

[32]  Tetsuya Komori,et al.  Furanoid-norditerpene aus Pflanzen der Familie Dioscoreaceae, IV1) Zur Struktur der Diosbulbine-A, -B und -C , 1973 .

[33]  A. Y. Lu,et al.  Partial purification of cytochromes P-450 and P-448 from rat liver microsomes. , 1972, Biochemical and biophysical research communications.

[34]  T. Kawasaki,et al.  Furanoid Norditerpenes from Dioscoreaceae Plants. I. Diosbulbins A, B and C from Dioscorea bulbifera L. forma spontanea MAKINO et NEMOTO , 1968 .